Pharmacokinetics of LEO 43204 Gel in Actinic Keratosis Administered Under Maximal Use Conditions
Phase of Trial: Phase I
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Ingenol disoxate (Primary)
- Indications Actinic keratosis
- Focus Pharmacokinetics
- Sponsors LEO Pharma
- 04 Dec 2017 Results published in the Clinical Drug Investigation
- 14 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jun 2015 Status changed from not yet recruiting to recruiting as per ClinicalTrials.gov.